KIRKLAND, Wash.--(BUSINESS WIRE)--Signostics, a start-up innovator in the field of highly miniaturized ultrasound technology, today announced the appointment of Mr. Jeffrey Markwood to the position of Chief Financial Officer (CFO) and Vice President of Administration. This announcement comes on the heels of Signostics hiring former SonoSite technology executive, Dr. Niko Pagoulatos, to the position of Executive Vice President and Chief Innovation Officer (CIO).
Mr. Markwood brings more than 25 years of senior and executive-level accounting and financial management experience to Signostics after holding a Senior Director position at SonoSite, where he worked alongside Signostics CEO Kevin Goodwin.
“Mr. Markwood is a data-driven leader whose wealth of experience developing and operating complex businesses will help advance Signostics as a global leader,” said CEO Kevin Goodwin.
Mr. Markwood became the Senior Director of Corporate Planning & Finance at Sonosite in 2009 where he oversaw the company’s financial planning and accounting operations worldwide for six years. While at Sonosite, Mr. Markwood was responsible for the implementation of the company’s planning platform as well as the consolidation of the company’s multiple platforms into one location.
Prior to SonoSite, Mr. Markwood spent 9 years at AT&T Wireless as Director of Financial Planning & Development where he broadened his expertise, moving from the accounting side of the business to the finance side. Mr. Markwood later joined Cyrk, a U.S. supplier of branded corporate merchandise, where he spent five years as Controller overseeing the company’s international operations.
“It’s a tremendous opportunity to join Signostics at such an exciting time,” said Mr. Markwood. “I am so thrilled to work with Kevin Goodwin once again. He is as innovative as leaders come, and he’s one of the driving forces behind this company.”
With this new hire, along with the recent announcement of a $35 million long-term investment from KKR, a leading global investment firm, Signostics is well-poised to advance its aggressive pursuit of cutting-edge medical innovations in addition to expanding and accelerating global marketing and distribution for new products.
The company recently moved its headquarters from Clovelly Park, South Australia to become a Delaware-based corporation with new headquarters in Kirkland, Washington.
About Signostics:
Signostics is a leader in handheld ultrasound devices and bladder scanners. Products include the SignosRT ultrasound system and the SignosRT Bladder, both ultra-portable, affordable devices designed to assist with the diagnosis of common medical presentations at the point of care. The company has regulatory approvals in place for Australia, the U.S., Canada, Japan, Singapore and Europe and currently exports to countries around the world.
